+36.1% · 90d
$27.05
+0.02 (+0.07%)
After-Hours $27.05(+0.00)
News
(1)April 2026
NGNE appoints CCO and board member for NGN-401 commercial readiness
NGNENeurogene Inc.
# 📰 What This Document Is 📣 This filing is an 8-K, which is a required SEC form used to announce major corporate events that shareholders and the public should know about immediately. In simple terms, it’s the company’s way of saying, "Hey, pay attention! We have big news." The announcement, made
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%